Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Disease area: Pulmonary vascular diseases

Abstract

Pulmonary arterial hypertension (PAH; OMIM #178600) is a progressive disease that causes the obstruction of precapillary pulmonary arteries. Syncope, dyspnea and chest pain are the main symptoms of PAH. Much of what is known about the genetic basis of PAH is related to BMPR2 gene. However, some other candidate genes have been advocated. The aim of this study was to analyse patients with combined mutations in BMPR2, ACVRL1, ENG and KCNA5 genes.We included 57 PAH patients and 50 controls. The DNA extraction was performed with the Qiagen DNA kit FlexiGene. Using specifically primers, we amplified and sequenced genes. Genotype-phenotype correlation was performed.After mutation screening of BMPR2, ACVRL1, ENG and KCNA5 genes, we identified pathogenic mutations in 40 patients. We found a high percentage of patients with several mutations classified as pathogenic by in silico analysis. Some patients had several mutations in the same gene whereas others harboured several mutations in different genes. We found combined mutations in BMPR2 gene in 25% of patients with several mutations included in this study. We detected one patient that show two pathogenic mutations in ENG gene. We found significant differences, comparing patients with several mutations and patients with one pathogenic mutation, for gender (p=0.045), age at diagnosis (p=0.040), PVR (p=0.030), CI (p=0.042) and no response to therapy (p=0.011).We show a series of patients with PAH with a high percentage of them being carriers of more than one pathogenic mutation in several genes. We wonder whether these additional mutations act as a second event in the development of the disease, increasing the penetrance or simply modifying the phenotype of patients.


Rating:

Share or cite this content

Citations should be made in the following way:
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Adolfo Baloira, Diana Valverde. Pulmonary arterial hypertension associated with several mutations. Eur Respir J 2016; 48: Suppl. 60, 2478

Member's Comments

No comment yet.

Related content which might interest you: Functional analysis of the 5´UTR region of BMPR2 gene in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4 Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Analysis of the subcellular localization in BMPR2 gene in pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Functional characterization of BMPR2 gene in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Mutational and epigenetic analysis of the promoter region of BMPR2 gene in patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 A new molecular genetic diagnostic approach for pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Female pulmonary arterial hypertension is associated with decreased microRNA96 expression Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Molecular study of genetic modifiers in patients with pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Pulmonary Function and response to treatment in pulmonary arterial hypertension (PAH) Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients Source: Eur Respir J 2012; 39: 597-603 Year: 2012 Smad1 deficiency and female gender contribute to the development of pulmonary hypertension Source: International Congress 2014 – Pathobiology of pulmonary hypertension Year: 2014 The evolution of effort tolerance and body composition in patients with idiopathic pulmonary arterial hypertension Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Molecular characterization of the ACVRL1 and ENG genes in patients with pulmonary arterial hypertension Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Pulmonary arterial hypertension associated to HIV. Our experience Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 LSC 2014 abstract - Combined effects of inflammatory mediators and BMPR2 mutation on pulmonary arterial cell function in a pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014